Bayer builds in Germany; Aventis splits from Novartis in vax venture;

> Bayer is investing $47 million in a facility in Wuppertal, Germany, to produce experimental biologics for its clinical trials. Release

> Sanofi-Aventis unit Aventis Pharma is selling its 49 percent stake in a vaccine-making company to partner Novartis. Story

> B2B trade board sellers are positioning themselves as drop shippers and order-fulfillment centers for Internet pharmacies. Release

> According to reports, Juhel Pharmaceutical Manufacturing's managing director Ifeanyi Okoye has been kidnapped in Anambra State, Nigeria, two months after the kidnapping of his mother. Article

> The Seoul Metropolitan Police have booked 15 pharmacists for importing fake Viagra from China. Story

> The Saudi Pharmaceutical Industry & Medical Appliances Corp. is one of several companies "leading the charge" to both import and produce pharmaceutical goods and equipment in the kingdom. Story

> Recovery from a decade-long economic contraction is driving growth in Zimbabwe's pharmaceutical sector. Release

> China's Lotus Pharmaceuticals is scrapping plans to build a facility in Inner Mongolia so it can focus on its core business in Beijing. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.